Invectys : lutter contre toutes les formes de cancers Avec 382 000 nouveaux cas et 157 400 décès par an, le cancer demeure une priorité absolue en matière de…
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. …
To help us orient our long-term decisions and strategy, we rely on an experienced and dependable board of seasoned industry professionals, investors and health care…
Invectys’ Scientific and Clinical Board is composed of globally recognized top specialists and key opinion leaders: Professor Maurizio Zanetti, M.D. A professor…
Invectys Inc. is led by a team of experienced industry professionals, combining vision, scientific knowledge and management skills. Dr. Jake Kushner, President…
